Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study
Main Authors: | Yeo, B, Zabaglo, L, Hills, M, Dodson, A, Smith, I, Dowsett, M |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522631/ |
Similar Items
-
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer
by: Barton, S, et al.
Published: (2012) -
A comparison of breast cancer prognostic tools; NPI+ and IHC4, and a development of IHC4 score calculator
by: Koufeya, Dooa
Published: (2015) -
The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study
by: Kuchel, Anna, et al.
Published: (2016) -
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
by: Gellert, Pascal, et al.
Published: (2016) -
The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.
by: Johnston, S. R., et al.
Published: (1997)